HIV pre-exposure prophylaxis (PrEP): a review of current knowledge of oral systemic HIV PrEP in humans

[1]  J. Baeten,et al.  Antiretroviral Pre-Exposure Prophylaxis Does Not Enhance Immune Responses to HIV in Exposed but Uninfected Persons. , 2015, The Journal of infectious diseases.

[2]  James Y. Dai,et al.  Tenofovir-based preexposure prophylaxis for HIV infection among African women. , 2015, The New England journal of medicine.

[3]  R. Baggaley,et al.  Young key populations and HIV: a special emphasis and consideration in the new WHO Consolidated Guidelines on HIV Prevention, Diagnosis, Treatment and Care for Key Populations , 2015, Journal of the International AIDS Society.

[4]  C. Beyrer.  Strategies to manage the HIV epidemic in gay, bisexual, and other men who have sex with men , 2014, Current opinion in infectious diseases.

[5]  J. Montaner,et al.  HIV treatment as prevention: the key to an AIDS-free generation. , 2013, Journal of food and drug analysis.

[6]  C. Hendrix,et al.  Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial , 2013, The Lancet.

[7]  C. Sabin,et al.  Life expectancy of HIV-1-positive individuals approaches normal conditional on response to antiretroviral therapy: UK Collaborative HIV Cohort Study , 2012, Journal of the International AIDS Society.

[8]  Peter L. Anderson,et al.  Emtricitabine-Tenofovir Concentrations and Pre-Exposure Prophylaxis Efficacy in Men Who Have Sex with Men , 2012, Science Translational Medicine.

[9]  A. Lansky,et al.  Interim guidance for clinicians considering the use of preexposure prophylaxis for the prevention of HIV infection in heterosexually active adults. , 2012, MMWR. Morbidity and mortality weekly report.

[10]  Katrien Fransen,et al.  Preexposure prophylaxis for HIV infection among African women. , 2012, The New England journal of medicine.

[11]  John T Brooks,et al.  Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. , 2012, The New England journal of medicine.

[12]  James D. Campbell,et al.  Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. , 2012, The New England journal of medicine.

[13]  Myron S. Cohen,et al.  HIV treatment as prevention and HPTN 052. , 2012, Current opinion in HIV and AIDS.

[14]  Myron S. Cohen,et al.  Penetration of Tenofovir and Emtricitabine in Mucosal Tissues: Implications for Prevention of HIV-1 Transmission , 2011, Science Translational Medicine.

[15]  L. Grohskopf,et al.  Bone Mineral Density in HIV-Negative Men Participating in a Tenofovir Pre-Exposure Prophylaxis Randomized Clinical Trial in San Francisco , 2011, PloS one.

[16]  T. Kelesidis,et al.  Preexposure Prophylaxis for HIV Prevention , 2011, Current HIV/AIDS reports.

[17]  W. Heneine,et al.  Intermittent Prophylaxis with Oral Truvada Protects Macaques from Rectal SHIV Infection , 2010, Science Translational Medicine.

[18]  S. Baral,et al.  The global epidemic of HIV infection among men who have sex with men , 2009, Current opinion in HIV and AIDS.

[19]  Michael Monsour,et al.  Prevention of Rectal SHIV Transmission in Macaques by Daily or Intermittent Prophylaxis with Emtricitabine and Tenofovir , 2008, PLoS medicine.

[20]  J. Stockman,et al.  Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men , 2012 .